DISHMAN CARBOGEN AMCIS
|
The Current P/B Ratio of DISHMAN CARBOGEN AMCIS is 0.75.
Share Price | ₹270.3 | Dec 24,2024 |
Market Cap | ₹4,238.3 Cr | |
Book Value | ₹5,627.5 Cr | Mar2024 - Consolidated Results |
Price/Book | 0.75x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of DISHMAN CARBOGEN AMCIS
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹4,238.3 Cr] as on Dec 24,2024
(/) Book Value [ ₹5,627.5 Cr] based on Mar2024 - Consolidated Results
(=) P/B Ratio [ 0.75x ]
Thus, for DISHMAN CARBOGEN AMCIS , the investors are currently willing to pay '0.75 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of DISHMAN CARBOGEN AMCIS !
The chart below summarizes the trend in P/B Ratio of DISHMAN CARBOGEN AMCIS over the last five years.
Historical PB (Price/Book ) ratio chart of DISHMAN CARBOGEN AMCIS
PB Ratio Performance Analysis for DISHMAN CARBOGEN AMCIS
- DISHMAN CARBOGEN AMCIS 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 0.39x.
- DISHMAN CARBOGEN AMCIS 's operated at median p/b ratio of 0.34x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, DISHMAN CARBOGEN AMCIS 's p/b ratio peaked in Mar2024 at 0.66x.
- DISHMAN CARBOGEN AMCIS 's p/b ratio hit its five-year low in Mar2020 of 0.15x.
How does DISHMAN CARBOGEN AMCIS 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
DISHMAN CARBOGEN AMCIS | 5,627.50 | 0.75 | 4,238.3 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 63,666.80 | 6.85 | 436,103.0 |
CIPLA LTD | 26,619.90 | 4.48 | 119,196.0 |
DR REDDYS LABORATORIES LTD | 28,123.50 | 4.01 | 112,752.0 |
ZYDUS LIFESCIENCES LTD | 19,829.50 | 4.89 | 97,041.2 |
DIVIS LABORATORIES LTD | 13,571.00 | 11.31 | 153,540.0 |
MANKIND PHARMA LTD | 9,339.84 | 12.86 | 120,073.0 |
TORRENT PHARMACEUTICALS LTD | 6,856.15 | 16.79 | 115,112.0 |
LUPIN LTD | 14,175.80 | 6.98 | 98,925.3 |
AUROBINDO PHARMA LTD | 29,842.80 | 2.46 | 73,314.6 |
ABBOTT INDIA LTD | 3,658.73 | 16.53 | 60,480.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs DISHMAN CARBOGEN AMCIS 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 0.75x |
Max industry PB | 16.79x |
Median industry PB | 6.85x |
Average industry PB | 7.99x |
You may also like the below Video Courses